Halia Therapeutics, Inc.

This study was designed to see if adding an experimental drug called ofirnoflast to the standard diabetes medication semaglutide helps obese or overweight adults with type 2 diabetes control their blood sugar and lose more weight. The trial planned to compare the combination agai…

This study tests an experimental drug called HT-6184 in adults with a low-risk form of myelodysplastic syndrome (MDS) who have anemia (low red blood cells). The goal is to see if the drug can improve blood counts and reduce the need for transfusions. Participants take the drug fo…